About AbbVie
AbbVies mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on peoples lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, womens health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.
This position reports into the Office of the Product Safety Team (PST) within the Pharmacovigilance and Patient Safety (PPS) organizations Global PV Strategy Management Office. The PPS organization works collaboratively and strategically with colleagues across the product lifecycle to identify, evaluate, understand and communicate the safety profile of our drugs to protect patients worldwide.
The Pharmacovigilance (PV) Partnership Alliance Team is a high-profile high-impact team that owns Pharmacovigilance Agreements (PV Agreements) and leads the PV Agreement strategy across the partnership lifecycle. The PV Partnership team plays a critical role partnering with internal stakeholders and external partners across the partnership lifecycle to ensure appropriate and timely exchange of safety information to maintain regulatory compliance. As the Manager, PV Partnership Alliance, you are in a highly visible role that provides various opportunities to drive the strategy and development of PV Agreements and related business processes and technologies.
Responsibilities:
* Builds, maintains and develops strategic partnerships with key internal (within and outside PPS) and external stakeholders to advance the department priorities in driving partnership and compliance excellence.
* Proactively identifies and escalates potential compliance related issues that may impact the ability to meet regulatory requirements and business goals
* Conducts Program and Supplier assessments to determine impact on PPS, regulations, and guidelines
* Independently negotiates, execute, and maintain global PV Agreements
* Drive implementation of obligations deriving from PV Agreements throughout PV functions.
* Monitors various internal reports adherence to PV Agreements, communicates issues, suggest and request corrective actions
* Trains internal and external partnerships on PV Agreement terms including but not limited to: Service Provider Training, On-boarding, and Annual Training
* Maintain electronic database to track global and local PV Agreements
* Provides Affiliate support in review and execution of local PV Agreements
* Acts as liaison within departments in PPS to ensure understanding, execution, and implementation of PV Agreements
Qualifications
Basic:
* Bachelors Degree with related health science background, BSN, BS, BS Pharm, PHarmD.
* Advanced degree preferred.
* Minimum 3 years pharma experience; 1-3 years should be pharmacovigilance experience
* Demonstrated ability to work effectively and collaboratively across the organization must have strong ability to build relationships both internally and externally
Significant Work Activities
Continuous sitting for prolonged periods (more than 2 consecutive hours in an 8 hour day)
Keyboard use (greater or equal to 50% of the workday)
Travel
No
Job Type
Experienced
Schedule
Full-time
Job Level Code
M
Equal Employment Opportunity
At AbbVie, we value bringing together individuals from diverse backgrounds to develop new and innovative solutions for patients. As an equal opportunity employer we do not discriminate on the basis of race, color, religion, national origin, age, sex (including pregnancy), physical or mental disability, medical condition, genetic information gender identity or expression, sexual orientation, marital status, protected veteran status, or any other legally protected characteristic.
Chicago, IL
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström’s macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.
It also provides KALETRA, an anti-human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; NORVIR, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and SYNAGIS to prevent respiratory syncytial virus infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron to treat prostate cancer, endometriosis, and central precocious puberty, as well as anemia.
Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson’s disease; Sevoflurane, an anesthesia product; and ORILISSA, a non-peptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain. It has collaborations with Alector, Inc.; Janssen Biotech, Inc.; Galapagos; Bristol-Myers Squibb Company; and Calico Life Sciences LLC. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.